Pfizer and BioNTech endorse 100% efficiency of vaccine for children

Pfizer and BioNTech in a joint statement have confirmed that their COVID-19 vaccine is 100% effective in protecting 12-15 years old children from contracting the coronavirus, Report informs.

The companies analyzed follow-up data for participants in the third phase of the clinical trials, which covered 2,200 children. Of the 30 confirmed cases of coronavirus infection, all were registered in the group of children, who were injected with a dummy medication, or the so-called innocuous medication.

The statement states that the companies will share research results with regulators in the US and other countries to scale up the use of the vaccine for children over 12 years of age. According to the statement, at this time in the United States, only emergency use of the vaccine for this age group is allowed.